Zimmer Biomet
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a global medical technology leader headquartered in Warsaw, Indiana, with operations spanning the United States, Europe, Asia Pacific, and other international markets. The company designs, manufactures, and markets a comprehensive portfolio of orthopedic reconstructive… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Zimmer Biomet does
In the company’s own words
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a global medical technology leader headquartered in Warsaw, Indiana, with operations spanning the United States, Europe, Asia Pacific, and other international markets. The company designs, manufactures, and markets a comprehensive portfolio of orthopedic reconstructive products, sports medicine and biologics, extremities and trauma solutions, craniomaxillofacial and thoracic products, bone cement, surgical instruments, and integrated digital and robotic technologies. The company's website is www.zimmerbiomet.com.
Zimmer Biomet operates through three primary geographic segments: the Americas, which represents the largest segment with the United States accounting for approximately 95 percent of regional sales; Europe, Middle East and Africa, the second-largest segment where France, Germany, Italy, Spain, and the United Kingdom collectively represent approximately 50 percent of regional sales; and Asia Pacific, where Japan comprises approximately 50 percent of regional sales. The company employs approximately 17,000 people worldwide, including roughly 2,000 dedicated to research and development and 6,000 in manufacturing operations, with approximately 7,000 employees in the United States and 10,000 internationally.
The company's product portfolio includes significant orthopedic brands such as the Persona Knee, NexGen Knee Implants, Taperloc Hip System, and Avenir Complete Hip System, along with the ROSA Robot for surgical assistance. The S.E.T. category encompasses sports medicine, biologics, foot and ankle, upper extremities, trauma, and craniomaxillofacial products. The company also markets the ZBEdge Platform, connecting robotic and digital technologies to collect surgical data and deliver patient insights.
Zimmer Biomet's history dates to 1927 with the founding of Zimmer Manufacturing Company. The company was spun off as an independent public company in 2001 and acquired Biomet in 2015, adopting its current name. The company maintains extensive research and development facilities across multiple locations including Warsaw, Montreal, Denver, Jacksonville, Austin, Zug, and Beijing. Consignment sales represent approximately 85 percent of net sales, reflecting the company's direct relationships with healthcare institutions and surgical centers.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- WARSAW, IN
- Fiscal year end
- December
- CIK
- 1136869
- SIC
- 3842
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Zimmer Biomet — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Zimmer Biomet · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Zimmer Biomet’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Zimmer Biomet’s bonds, as funds hold them
Funds report holding 12 issues of Zimmer Biomet’s debt, $1.15B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.63%, maturing 2026 to 2045.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Zimmer Biomet and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Zimmer Biomet's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Zimmer Biomet's last four quarterly filings that the numbers alone won't show?”